Company intelligence / Profile preview

Nagel Avenue Capital

Wayzata, Minnesota, United States

Ownership: Private
Development stage: Other

Overview

Nagel Avenue Capital is a private investment firm specializing in the medical technology and healthcare services sectors. Founded in 2017 by Michael J. Nagel, the former CEO of Vascular Solutions, the firm focuses on providing growth capital and strategic operational guidance to early and growth-stage companies. Nagel Avenue Capital leverages the deep industry experience of its leadership to identify innovative medical devices and healthcare delivery models with significant market potential. The firm's portfolio has included notable investments in companies such as VentureMed Group and Standard Bariatrics, the latter of which was successfully acquired by Teleflex. Based in Minnesota, Nagel Avenue Capital remains an active participant in the MedTech investment landscape.

Industry: Investors

Beyond the preview

Go deeper on Nagel Avenue Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nagel Avenue Capital.

Explore the full profile